Virginia Juan-Calvo
Majadahonda, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Clinical Characteristics and Survival Outcomes in Patients With Small Cell Lung Cancer in Spain: An Analysis of the Thoracic Tumor Registry (2016-2025).
Journal: Archivos de bronconeumologia
Published: January 13, 2026
Management of borderline resectable NSCLC: a narrative review.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: May 05, 2025
Family history of cancer and lung cancer: Utility of big data and artificial intelligence for exploring the role of genetic risk.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 06, 2024
Analysis of Diagnostic Delay and its Impact on Lung Cancer Survival: Results From the Spanish Thoracic Tumor Registry.
Journal: Archivos de bronconeumologia
Published: May 28, 2024
Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients.
Journal: Archivos de bronconeumologia
Published: November 06, 2023
Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: October 26, 2023
Difficulties on the access to innovative targeted therapies for lung cancer in Spain.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: July 25, 2023
Addressing lung cancer screening eligibility in Spain using 2013 and 2021 US Preventive Service Task Force criteria: cross-sectional study.
Journal: ERJ open research
Published: July 10, 2023
Are there differences by sex in lung cancer characteristics at diagnosis? -a nationwide study.
Journal: Translational lung cancer research
Published: July 09, 2021
Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group.
Journal: BMC cancer
Published: September 20, 2020
Lung cancer symptoms at diagnosis: results of a nationwide registry study.
Journal: ESMO open
Published: August 31, 2020
Overall survival for early and locally advanced non-small-cell lung cancer from one institution: 2000-2017.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: May 29, 2020
Last Updated: 09/26/2026